PPLadmin – Phoenix PharamLabs

Dr. Lawrence Toll Presents at NCATS-Sponsored Symposium

PPLadmin2019-02-09T00:23:13+00:00

Phoenix PharmaLabs is very pleased to announce that our chief neuropharmacologist and co-founder, Dr. Lawrence Toll, will present a poster entitled: “In Vitro and In Vivo Profile of PPL-103: A Mixed Opioid Partial Agonist Analgesic or Drug Abuse Medication”, at the upcoming National Center for Advancing Translational Sciences (NCATS)-sponsored symposium The Opioid Crisis and the Future of Addiction [...]

Dr. Lawrence Toll Presents at NCATS-Sponsored SymposiumPPLadmin2019-02-09T00:23:13+00:00

Phoenix PharmaLabs Announces Investment Offering to Support Additional Research of Non-Addictive Opioid

PPLadmin2018-10-17T14:38:40+00:00

BioSpace Global Banking & Finance Review

Phoenix PharmaLabs Announces Investment Offering to Support Additional Research of Non-Addictive OpioidPPLadmin2018-10-17T14:38:40+00:00

How to fight drug addiction: the shift to prescription drugs

PPLadmin2018-09-27T16:33:05+00:00

Full Article

How to fight drug addiction: the shift to prescription drugsPPLadmin2018-09-27T16:33:05+00:00

How a stepson’s addiction drove a father to try to develop a safer opioid

PPLadmin2018-09-27T16:32:29+00:00

Full Article

How a stepson’s addiction drove a father to try to develop a safer opioidPPLadmin2018-09-27T16:32:29+00:00

One Stepfather’s Quest: The Search For An Opioid That Won’t Lead To Addiction

PPLadmin2018-09-27T16:31:15+00:00

Full Article

One Stepfather’s Quest: The Search For An Opioid That Won’t Lead To AddictionPPLadmin2018-09-27T16:31:15+00:00

Novel Non-Addictive Opioid Described at CPDD Annual Meeting in San Diego

PPLadmin2018-09-27T16:30:12+00:00

Download PDF

Novel Non-Addictive Opioid Described at CPDD Annual Meeting in San DiegoPPLadmin2018-09-27T16:30:12+00:00

Phoenix PharmaLabs Exec Describes Novel Non-Addictive Opioid

PPLadmin2018-09-27T16:28:58+00:00

Full Article

Phoenix PharmaLabs Exec Describes Novel Non-Addictive OpioidPPLadmin2018-09-27T16:28:58+00:00

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.

PPLadmin2018-09-27T16:28:11+00:00

Full Article

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.PPLadmin2018-09-27T16:28:11+00:00

Research Declares Phoenix PharmaLabs’ Opioid PPL-103 Safe

PPLadmin2018-09-27T16:24:38+00:00

Full Article

Research Declares Phoenix PharmaLabs’ Opioid PPL-103 SafePPLadmin2018-09-27T16:24:38+00:00

n Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential

PPLadmin2018-09-27T16:22:43+00:00

Full Article

n Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse PotentialPPLadmin2018-09-27T16:22:43+00:00

About PPLadmin